Monz takes over as ceo of Carl Zeiss Meditec

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec.

Ludwin Monz has been named as chief executive of Carl Zeiss Meditec. He takes over from Michael Kaschke, who resumes his role as chairman of the company's supervisory board.

Monz has been a member of Carl Zeiss Meditec's management board since October 2007 and is responsible for the firm's Ophthalmological Systems division. Prior to this he led the Microsurgery division for six years.

With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.

You may also like

Packaging
Kallik warns pharma manufacturers against AI ‘compliance timebomb’

Kallik warns pharma manufacturers against AI ‘compliance timebomb’

Labelling software specialist Kallik has said pharmaceutical manufacturers should prioritise data quality before deploying AI, warning that poor data governance could increase compliance risks and product recalls
Digital
LifeArc and RDR UK launch Raremap to strengthen rare disease research collaboration

LifeArc and RDR UK launch Raremap to strengthen rare disease research collaboration

The new online directory will aim to connect researchers, clinicians, charities, patient groups and industry, helping accelerate collaboration across the UK rare disease ecosystem
Research & Development
Novogene Europe launches untargeted metabolomics service at Cambridge Omics Centre

Novogene Europe launches untargeted metabolomics service at Cambridge Omics Centre

The LC-MS workflow, built on Thermo Fisher's Orbitrap Exploris 120, adds small-molecule profiling to Novogene's genomics and transcriptomics capabilities, strengthening multiomics support for disease mechanism, biomarker and microbiome research across Europe
Media
Plan your marketing strategy with Manufacturing Chemist

Plan your marketing strategy with Manufacturing Chemist

Discover upcoming special reports, themed features and commercial opportunities to help you connect with pharmaceutical manufacturing decision-makers throughout the year
Digital
Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

The AI-driven biotech and China Medical System have struck a second collaboration in three months, targeting a mass-market CNS indication via a novel mechanism identified by Insilico's PandaOmics platform
Packaging
FINAT Recognises Digital Security Seal from Schreiner MediPharm

FINAT Recognises Digital Security Seal from Schreiner MediPharm

Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, received the prestigious Group Award for Innovation for a newly developed security seal with an integrated digital authentication function in the FINAT Label Competition 2026
Digital
Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations

The digital data fabric links R&D, analytical development and GMP manufacturing, replacing periodic reporting with continuous audit-ready transparency aligned to FDA, EMA and PMDA expectations
Subscribe now